Kirsten Grønbæk

Medicin og biovidenskab

1. Mantle-Cell Lymphoma 100%
2. Lymphoma, Large B-Cell, Diffuse 73%
3. Myelodysplastic Syndromes 67%
4. Neoplasms 63%
5. Epigenomics 62%
6. Mutation 59%
7. Methylation 58%
8. DNA Methylation 44%
9. MicroRNAs 38%
10. Lymphoma 37%
11. Survival 34%
12. Azacitidine 33%
13. Genes 31%
14. Circular RNAs 27%
15. B-Lymphocytes 26%
16. Lenalidomide 24%
17. Acute Myeloid Leukemia 23%
18. Therapeutics 22%
19. B-Cell Lymphoma 22%
20. Rituximab 21%
21. DNA 19%
22. T-Lymphocytes 19%
23. Multiple Myeloma 19%
24. Leukemia, Myelomonocytic, Chronic 19%
25. GATA2 Deficiency 19%
26. Hematopoiesis 19%
27. High-Throughput Nucleotide Sequencing 18%
28. Methyltransferases 17%
29. Hematologic Neoplasms 16%
30. Progression-Free Survival 15%
31. Cytarabine 14%
32. Decitabine 14%
33. Cutaneous T-Cell Lymphoma 14%
34. Ascorbic Acid 13%
35. Glioblastoma 13%
36. Polymerase Chain Reaction 13%
37. Denmark 13%
38. Epigenome 12%
39. Autoimmune Lymphoproliferative Syndrome 12%
40. Genome 12%
41. Down-Regulation 12%
42. Stem Cell Transplantation 12%
43. Twins 11%
44. Recurrence 11%
45. Population 11%
46. Bone Marrow 11%
47. B-Cell Chronic Lymphocytic Leukemia 11%
48. Cell Line 11%
49. Missense Mutation 11%
50. Pharmaceutical Preparations 11%